Exabis Library
Welcome to the e-CCO Library!
P701 New onset spondyloarthropathy in vedolizumab treated IBD patients 
 2020
ECCO'20 Vienna
 Thursday, 30 January 2020, 10:12 AM
P701: A time-to-event model relating infliximab trough concentrations to the risk of relapse after extending the infusion interval
 2023
 ECCO’23 Copenhagen
 Friday, 14 July 2023, 11:12 AM
P701: Compositional and functional alterations of the gut microbiome are associated with impaired intestinal permeability in healthy relatives of patients with Crohn's disease
 2022
 ECCO'22
 Friday, 11 February 2022, 3:56 PM
P701: Late-onset Crohn's disease is associated with high risk of intestinal perforation and low risk of perianal fistula as compared with early-onset Crohn's disease: the CONNECT cohort
 2017
 ECCO '17 Barcelona
 Wednesday, 20 February 2019, 10:36 AM
P701: Quality of life of patients with inflammatory bowel diseases who live with an ostomy: Results of a French national survey
 2018
 ECCO '18 Vienna
 Thursday, 21 February 2019, 9:14 AM
P701: The comparative safety of different intravenous iron preparations in inflammatory bowel disease: a systematic review and network meta-analysis 
 2019
ECCO '19 Copenhagen
 Friday, 22 February 2019, 9:41 AM
P702 Treatment decisions in older inflammatory bowel disease patients: Applying gut feeling in an evidence-based era? A qualitative study 
 2020
ECCO'20 Vienna
 Thursday, 30 January 2020, 10:12 AM
P702: Clinical and biomarker remission is maintained after switch from monthly dosed intravenous to subcutaneous maintenance treatment with vedolizumab in Inflammatory Bowel Disease
 2023
 ECCO’23 Copenhagen
 Friday, 14 July 2023, 11:12 AM
P702: F-calprotectin use in inflammatory bowel disease is characterized by improved diagnostic accuracy, less patient harm and decreased costs, compared with conventional serological markers and colonoscopy. A cost-effectiveness study in Italy
 2017
 ECCO '17 Barcelona
 Wednesday, 20 February 2019, 10:36 AM
P702: Faecal Microbiota Transplantation Sculpts the faecal and mucosal microbial and metabolomic profiles in patients with Ulcerative Colitis
 2022
 ECCO'22
 Friday, 11 February 2022, 3:56 PM
P702: Head-to-head comparison of biological drugs in the treatment of ulcerative colitis: Suggestions from a real-life, inception cohort, single-centre study on consecutive post-marketing treatments
 2018
 ECCO '18 Vienna
 Thursday, 21 February 2019, 9:14 AM
P702: Off-label drug use in patients with inflammatory bowel disease: a national survey among tertiary care centres 
 2019
ECCO '19 Copenhagen
 Friday, 22 February 2019, 9:41 AM
P703 Addition of azathioprine to switch of anti-TNF in patients with IBD in clinical relapse with pharacokinetic failure: A post hoc analysis of a prospective randomised trial using drug-tolerant assay 
 2020
ECCO'20 Vienna
 Thursday, 30 January 2020, 10:12 AM
P703: Clinical, radiographic and endoscopic remission with vedolizumab treatment in Crohn’s disease
 2018
 ECCO '18 Vienna
 Thursday, 21 February 2019, 9:14 AM
P703: Gut bacteria composition and familiality echo Inflammatory Bowel Disease type and pathological spectrum
 2022
 ECCO'22
 Friday, 11 February 2022, 3:56 PM
P703: Real world experience of the transition from the intravenous to subcutaneous formulation of vedolizumab in inflammatory bowel disease: A review of current data
 2023
 ECCO’23 Copenhagen
 Friday, 14 July 2023, 11:12 AM
P703: Risk of disease progression in patients with Crohn's disease after 7 years of follow-up in a Danish population-based inception cohort
 2017
 ECCO '17 Barcelona
 Wednesday, 20 February 2019, 10:36 AM
P703: The real-world long-term effectiveness of vedolizumab in inflammatory bowel diseases: a single-centre observational study 
 2019
ECCO '19 Copenhagen
 Friday, 22 February 2019, 9:41 AM
P704 The biennial direct pharmaceutical costs per treatment with biologics for the inflammatory bowel disease in Greece: A comparative calculation study 
 2020
ECCO'20 Vienna
 Thursday, 30 January 2020, 10:12 AM
P704: Association between trough levels of vedolizumab and therapy outcome in a cohort of patients with inflammatory bowel disease 
 2019
ECCO '19 Copenhagen
 Friday, 22 February 2019, 9:41 AM